Paul Calabresi
#138,873
Most Influential Person Now
Paul Calabresi's AcademicInfluence.com Rankings
Paul Calabresiphilosophy Degrees
Philosophy
#7148
World Rank
#10319
Historical Rank
Logic
#4218
World Rank
#5483
Historical Rank

Download Badge
Philosophy
Why Is Paul Calabresi Influential?
(Suggest an Edit or Addition)Paul Calabresi's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Chemotherapy of neoplastic diseases. (1962) (403)
- Heterogeneity in drug sensitivity among tumor cell subpopulations of a single mammary tumor. (1978) (325)
- N,N-dimethylformamide-induced alteration of cell culture characteristics and loss of tumorigenicity in cultured human colon carcinoma cells. (1979) (269)
- Role of p21 in Apoptosis and Senescence of Human Colon Cancer Cells Treated with Camptothecin* (2002) (261)
- High-dose intravenous methotrexate for patients with nonleukemic leptomeningeal cancer: is intrathecal chemotherapy necessary? (1998) (261)
- Psoriasis and occlusive vascular disease (1978) (205)
- Platelet-derived growth factor indirectly stimulates angiogenesis in vitro. (1993) (180)
- A sensitive ELISPOT assay to detect low-frequency human T lymphocytes. (1997) (174)
- Porto-caval and porto-pulmonary anastomoses in Laennec's cirrhosis and in heart failure. (1957) (166)
- Heterogeneity of cancer cells from a single human colon carcinoma. (1981) (164)
- Human microvascular endothelial cells express receptors for platelet-derived growth factor. (1991) (160)
- Tumor angiogenesis as a prognostic factor in cervical carcinoma. (1995) (152)
- Immunosuppressive effects of cytosine arabinoside and methotrexate in man. (1969) (133)
- Biochemical and pharmacological studies with 1-beta-D-arabinofuranosylcytosine in man. (1966) (133)
- Clinical and pharmacological implications of cancer cell differentiation and heterogeneity. (1979) (131)
- Use of allopurinol for prevention and control of hyperuricemia in patients with neoplastic disease. (1966) (121)
- Identification of the enzymatic pathways of nucleotide metabolism in human lymphocytes and leukemia cells. (1973) (116)
- Differential responses to x-irradiation of subpopulations of two heterogeneous human carcinomas in vitro. (1982) (113)
- Initial clinical studies with 5-iodo-2'-deoxyuridine. (1961) (109)
- Paclitaxel disposition in plasma and central nervous systems of humans and rats with brain tumors. (1995) (105)
- Fluorescent antiglobulin studies in leukopenic and related disorders. (1959) (104)
- Cell‐mediated and serum blocking reactivity to tumor antigens in patients with malignant melanoma (1973) (96)
- Actions of TNF and INF-γ on Angiogenesis In Vitro (1990) (81)
- Problems in the clinical use of the microcytotoxicity assay for measuring cell-mediated immunity to tumor cells. (1975) (78)
- Potentiation of 5-fluoro-2'-deoxyuridine antineoplastic activity by the uridine phosphorylase inhibitors benzylacyclouridine and benzyloxybenzylacyclouridine. (1984) (76)
- Taurolidine: cytotoxic and mechanistic evaluation of a novel antineoplastic agent. (2001) (69)
- Nucleotide profiles of the formed elements of human blood determined by high-pressure liquid chromatography. (1973) (69)
- Preoperative pulmonary function testing (1990) (69)
- 5-Fluorouracil enhances azidothymidine cytotoxicity: in vitro, in vivo, and biochemical studies. (1990) (68)
- Antitumor activity of basic fibroblast growth factor-saporin mitotoxin in vitro and in vivo. (1992) (66)
- Treatment of advanced Wegener's granulomatosis with azathioprine and duazomycin A. (1968) (65)
- Clinical and pharmacological studies with 2',3',5'-triacetyl-6-azauridine. (1963) (62)
- In vivo selection of a highly metastatic cell line from a human pancreatic carcinoma in the nude mouse (1992) (60)
- Establishment and characterization of two human pancreatic cancer cell lines tumorigenic in athymic mice. (1982) (59)
- Summary of current information on 6-azauridine. (1962) (59)
- Inhibition of the growth of human colon cancer xenografts by polar solvents. (1982) (57)
- The Granulocyte Response to an Endotoxin (Pyrexal) as a Measure of Functional Marrow Reserve in Cancer Chemotherapy (1962) (54)
- CURRENT STATUS OF CLINICAL INVESTIGATIONS WITH 6-AZAURIDINE, 5-IODO-2'-DEOXYURIDINE, AND RELATED DERIVATIVES. (1963) (54)
- DEMONSTRATION OF CIRCULATING ANTINUCLEAR GLOBULINS IN ULCERATIVE COLITIS. (1961) (53)
- Intraneoplastic diversity. (1982) (52)
- Polycythemia vera. I. Clinical and laboratory manifestations. (1959) (52)
- Alteration of the survival response of two human colon carcinoma subpopulations to x-irradiation by N,N-dimethylformamide. (1982) (52)
- Chemotherapy of cell‐line‐derived human colon carcinomas in mice immunosuppressed with antithymocyte serum (1977) (50)
- The “induction” of leukocyte and erythrocyte dihydrofolate reductase by methotrexate (1965) (48)
- Cardiac rehabilitation services (1988) (48)
- Medical Oncology: Basic Principles and Clinical Management of Cancer (1993) (47)
- Intrinsic and extrinsic characteristics of human tumors relevant to radiosurgery: comparative cellular radiosensitivity and hypoxic percentages. (1994) (45)
- Benzylacyclouridine reverses azidothymidine-induced marrow suppression without impairment of anti-human immunodeficiency virus activity. (1990) (45)
- Suppression by cytosine arabinoside of serum-blocking factors of cell-mediated immunity to syngeneic transplants of mouse mammary tumors. (1972) (43)
- Selective suppression of humoral immunity by antineoplastic drugs. (1976) (43)
- Alterations in human pyrimidine metabolism as a result of therapy with 6-azauridine. (1961) (43)
- Actions of TNF and IFN-gamma on angiogenesis in vitro. (1990) (42)
- Cytotoxic liponucleotide analogs. II. Antitumor activity of CDP-diacylglycerol analogs containing the cytosine arabinoside moiety. (1980) (42)
- Azidothymidine-induced cytotoxicity and incorporation into DNA in the human colon tumor cell line HCT-8 is enhanced by methotrexate in vitro and in vivo. (1992) (42)
- Heterogeneity of potential for hematogenous metastasis in a human pancreatic carcinoma. (1990) (41)
- RADIATION AND 5-FLUOROURACIL: A CONTROLLED CLINICAL STUDY. (1963) (40)
- N,N-dimethylformamide and sodium butyrate modulation of the activities of purine-metabolizing enzymes in cultured human colon carcinoma cells. (1981) (40)
- Phase I clinical and pharmacological studies of benzylacyclouridine, a uridine phosphorylase inhibitor. (1998) (39)
- Use of growth factors in the elderly patient with cancer: a report from the Second International Society for Geriatric Oncology (SIOG) 2001 meeting. (2003) (39)
- Selective suppression of humoral and cellular immunity with cytosine arabinoside. (1972) (38)
- A phase I trial of continuous infusion cisplatin (1987) (38)
- Detection of chemical mutagens using a host-mediated assay (L5178Y) mutagenesis system. (1974) (37)
- Suppression of Infections Resulting from a Deoxyribonucleic Acid Virus (Vaccinia) By Systemic Administration of 5-Iodo-2′-Deoxyuridine (1963) (37)
- Modulation of bleomycin‐induced pulmonary toxicity in the hamster by the antioxidant amifostine (1998) (37)
- The Effects of Taurolidine, a Novel Antineoplastic Agent, on Human Malignant Mesothelioma (2004) (35)
- Mechanistic and antineoplastic evaluation of taurolidine in the DU145 model of human prostate cancer (2004) (34)
- A prototype for a hybrid artificial liver. (1978) (33)
- Effect of sequence of administration of methotrexate, leucovorin, and 5-fluorouracil on mammary tumor growth and survival in syngeneic C3H mice. (1977) (33)
- Activities of purine-metabolizing enzymes in human colon carcinoma cell lines and xenograft tumors. (1981) (32)
- Drug therapy. Immunosuppressive agents. I. (1973) (31)
- Thrombospondin-1 plus irinotecan: a novel antiangiogenic-chemotherapeutic combination that inhibits the growth of advanced human colon tumor xenografts in mice (2004) (31)
- Clinical and pharmacological studies with 5-iodo-2'-deoxycytidine. (1963) (30)
- A synopsis of recent investigations of 6-azauridine (NSC-32074). (1960) (30)
- A clinical and pharmacological study of high-dose methotrexate with minimal leucovorin rescue. (1979) (30)
- Thermal survival characteristics of cell subpopulations isolated from a heterogeneous human colon tumor. (1983) (29)
- Effects of 1 alpha, 25-dihydroxyvitamin D3 on the human chronic myelogenous leukemia cell line RWLeu-4. (1990) (28)
- Drug therapy: immunosuppressive agents (second of two parts). (1973) (27)
- CLINICAL STUDIES WITH SYSTEMIC ADMINISTRATION OF ANTIMETABOLITES OF PYRIMIDINE NUCLEOSIDES IN VIRAL INFECTIONS * (1965) (27)
- The effect of Taurolidine on adherent and floating subpopulations of melanoma cells (2003) (27)
- Combined modality therapy for stage IIIA non-small cell carcinoma of the lung. (1993) (27)
- Diagnostic evaluation of the carotid arteries (1988) (26)
- The antibacterial drug taurolidine induces apoptosis by a mitochondrial cytochrome c-dependent mechanism. (2002) (26)
- Selective modification of the X ray survival response of two mouse mammary adenocarcinoma sublines by N,N-dimethylformamide. (1981) (25)
- Ultrastructure of myeloma cells in a case with crystalcryoglobulinemia (1977) (25)
- Synergism of methotrexate with imuran and with 5-fluorouracil and their effects on hemolysin plaque-forming cell production in the mouse. (1974) (24)
- Detection of elevated basic fibroblast growth factor during early hours of in vitro angiogenesis using a fast ELISA immunoassay. (1994) (24)
- Training program in medical oncology. (1973) (23)
- Evaluation of patients after recent acute myocardial infarction. American College of Physicians. (1989) (23)
- OBSERVATIONS ON OLFACTORY INTENSITY. I. TRAINING PROCEDURE, METHODS, AND DATA FOR TWO ALIPHATIC HOMOLOGOUS SERIES (1954) (23)
- Amifostine cytotoxicity and induction of apoptosis in a human myelodysplastic cell line. (2000) (23)
- Oral zidovudine, continuous-infusion fluorouracil, and oral leucovorin calcium: a phase I study. (1990) (21)
- Human IgG cryoglobulin with tubular crystal structure. (1973) (21)
- Amifostine modulation of bleomycin-induced lung injury in rodents. (1999) (21)
- Inhibition by 5-Iododeoxyuridine of the Oncogenic Effects of Adenovirus Type 12 in Hamsters (1963) (21)
- Quantification and pharmacological dissection of oxazolone-induced contact sensitivity in the mouse. (1974) (20)
- Alteration of antibody synthesis in the rat by cytosine arabinoside. (1969) (20)
- Different effect of benzylacyclouridine on the toxic and therapeutic effects of azidothymidine in mice (1990) (20)
- Selective alteration of immunocompetence with methotrexate and 5-fluorouracil. (1974) (20)
- Taurolidine: preclinical evaluation of a novel, highly selective, agent for bone marrow purging (2002) (20)
- Polycythemia vera. II. Course and therapy. (1959) (20)
- Regional protection in cancer chemotherapy. 1. Infusions of thymidine into external carotid artery of patients receiving systemic 5-iodo-2'-deoxyuruidine. (1962) (20)
- Selection of metastatic variants from heterogeneous tumor cell lines using the chicken chorioallantoic membrane and nude mouse. (1983) (18)
- Basic fibroblast growth factor production and growth factor receptors as potential targets for melanoma therapy (1992) (18)
- Metastasis of a human pancreatic adenocarcinoma (RWP-1) in nude mice. (1982) (18)
- Detection of carcinoembryonic antigen in the media of cultures of carcinomatous cells of digestive-system origin. (1972) (17)
- Response of a human colon adenocarcinoma (DLD-1) to X irradiation and mitomycin C in vivo. (1983) (16)
- Investigations with 5‐azaorotic acid, an inhibitor of the biosynthesis of pyrimidines de novo (1965) (16)
- Tissue-specific expansion of uridine pools in mice. Effects of benzylacyclouridine, dipyridamole and exogenous uridine. (1991) (15)
- Alteration of immunocompetence by mammary tumor virus. (1973) (15)
- Increased activity of alkaline phosphatase in leukemic cells from patients resistant to thiopurines. (1979) (15)
- Differential expression of tumor-associated antigens in human colon carcinomas xenografted into nude mice. (1983) (15)
- "COLO 357," a human pancreatic adenosquamous carcinoma: growth in artificial capillary culture and in nude mice. (1983) (14)
- Myeloproliferative syndrome with leukemia preceding polycythemia vera; a case report. (1958) (14)
- 5-Iodo-2'-deoxyuridine (IUDR; NSC-39661) given intraventricularly in the treatment of progressive multifocal leukoencephalopathy. (1973) (14)
- Continuous-infusion cisplatin and bolus 5-fluorouracil in colorectal carcinoma. (1987) (14)
- Cancer: crab or chimera? The clinical implications of cancer cell heterogeneity. (1981) (14)
- Cell culture of the mucinous variant of human colorectal carcinoma. (1988) (14)
- Basic principles and clinical management of cancer (1988) (13)
- How to study the gallbladder (1988) (12)
- Cytological screening for uterine cancer through physicians' offices; report of 65,163 women examined over a period of ten years (1947-1956). (1958) (12)
- Cancer at a crossroads : a report to Congress for the nation (1995) (11)
- Regional protection in cancer chemotherapy. II. Preliminary studies with hypogastric artery infusion of thymidine during treatment with 5-iodo-2'-deoxyuridine. (1962) (11)
- Inhibition of growth factor mitogenicity and growth of tumor cell xenografts by a sulfonated distamycin A derivative. (1997) (11)
- Demonstration of L. E. cells at local inflammatory sites in patients with systemic lupus erythematosus. (1960) (11)
- Pharmacological and clinical studies with triacetyl 6-azauridine. (1962) (11)
- Differential characteristics of two newly established human breast carcinoma cell lines. (1985) (10)
- Selective immunosuppression by drugs in balanced immune responses. (1974) (10)
- Receptors for platelet-derived growth factor on microvascular endothelial cells. (1992) (10)
- Recombinant interferon α2a synergistically enhances ganciclovir-mediated tumor cell killing in the herpes simplex virus thymidine kinase system (1999) (10)
- Indications for carotid endarterectomy (1989) (10)
- Biochemical pharmacology and toxicology of 8-azaadenosine alone and in combination with 2'-deoxycoformycin (pentostatin). (1982) (10)
- Gene-modified cells for the treatment of cancer. (1995) (9)
- Gene-modified cells for the treatment of cancer. (1995) (9)
- Leukemia after cytotoxic chemotherapy--a pyrrhic victory? (1983) (9)
- Successful therapy of crystalcryoglobulinemia: a case report. (1979) (9)
- Continuous intravenous infusions of 5‐fluoro‐2′‐deoxyuridine in the treatment of solid tumors (1973) (9)
- Monoclonal antibody production in artificial capillary cultures. Abstr. (1981) (8)
- Enhanced Suppression of the Secondary Immune Response by Combination of 6-Mercaptopurine ‘Duazomycin A’ (1963) (8)
- Concerns of special populations (1997) (8)
- Clinical, pharmacologic, and immunologic effects of 2'‐deoxycoformycin (1988) (8)
- The metabolism of uracil‐2‐14C and the granulocyte response to endotoxin as indicators of the toxicity produced in patients receiving 5‐fluorouracil (1967) (8)
- Hemodynamic effects of potentially useful antineoplastic agents. (1983) (8)
- Tumor-associated antigens produced by mouse mammary tumor cells in artificial capillary culture. (1982) (7)
- Clinical and pharmacologic effects of combinations of 6-thioguanine and duazomycin A in patients with neoplastic disease. (1965) (7)
- Nude mouse model of the melanosis syndrome. (1983) (7)
- NUCLEOSIDE ANALOGS IN THE TREATMENT OF NONNEOPLASTIC DISEASES * (1975) (7)
- Endotoxin stimulation in patients with lymphoma: correlation with the myelosuppressive effects of alkylating agents. (1972) (7)
- Tumor immunity in melanoma patients as assessed by colony inhibition and microcytotoxicity methods: a preliminary report. (1973) (7)
- Survival responses of cell subpopulations isolated from a heterogeneous human colon tumour after combinations of hyperthermia and X-irradiation. (1983) (7)
- Cancer Cell Differentiation (1982) (6)
- Protection against hyperthermic cell killing of mouse mammary adenocarcinoma cells in vitro by N,N-dimethylformamide. (1981) (6)
- RECENT STUDIES WITH 5-IODODEOXYURIDINE (IUDR) AND RELATED COMPOUNDS. (1963) (6)
- Medical oncology manpower training: a position statement of the American Society of Clinical Oncology. (1985) (6)
- A role for MAP kinase in the antitumor activity of a nucleoside analog (2002) (6)
- Benzylacyclouridine Enhances 5-Fluorouracil Cytotoxicity against Human Prostate Cancer Cell Lines (1998) (6)
- Stimulation of hemolysin plaque-forming cells by idoxuridine. (1975) (6)
- Simplified estimation of mouse isohemagglutinins by microassay. (1969) (6)
- The use of 5-iodo-2'-deoxyuridine (IUDR) in Orabase and plastibase for treatment of oral herpes simplex. (1969) (5)
- Demonstration of cell-mediated and blocking immune responses to tumor antigens in cancer patients with the colony-inhibition-in-gel test. (1973) (5)
- Microanalysis For Platinum and Magnesium in Body Fluids and Brain Tissue of Mice Treated with Cis-Platinum Using Graphite Filament Plasma Emission Spectroscopy (1986) (5)
- Clinical experiences with 5-fluorouracil. (1960) (5)
- Principles of current cancer chemotherapy. (1983) (5)
- Responses of oxic and hypoxic human colon tumor cells to hyperthermia. (1982) (5)
- Enhanced Suppression of Experimental Allergic Encephalomyelitis by Combination Chemotherapy with Duazomycin-A and 6-Mercaptopurine∗ (1969) (5)
- Predictive Sensitivity of Human Cancer Cells in vivo Using Semipermeable Polysulfone Fibers (1998) (5)
- Medical alternatives to alternative medicine (1999) (5)
- Immunosuppressive Effects of Selected Metabolic Inhibitors in Vivo and in Vitro ∗ (1968) (5)
- Synthesis and biological evaluation of certain 4‐alkylamino and 4‐arylalkylamino derivatives of the imidazo[4,5‐d]pyridazine and v‐triazolo[4,5‐d]pyridazine ring systems (1982) (4)
- CELLULAR AND BIOCHEMICAL ASPECTS OF HUMAN TUMOR CELL GROWTH AND FUNCTION IN HOLLOW FIBER CULTURE (1985) (4)
- Modification of the response of mouse skin to x-irradiation by a polar solvent, N,N-dimethylformamide. (1982) (4)
- A Phase I‐II Trial of Continuous‐Infusion Cisplatin, Continuous‐Infusion 5‐Fluorouracil, and VP‐16 in Colorectal Carcinoma (1990) (4)
- Immunologic Tolerance in Rats to Type Specific Antigens of Human Erythrocytes.∗ † (1958) (4)
- Training programs in medical oncology. (1986) (4)
- Clinical trial of weekly pyrazofurin. (1979) (4)
- Evaluation of cell-mediated reactivity and serum blocking factors in melanoma patients on chemotherapy. (1975) (4)
- Clinical pharmacokinetics of 3-day continuous infusion cisplatin and daily bolus 5-Fluorouracil (2004) (3)
- Biochemical pharmacology and toxicology of formycin alone and in combination with 2'-deoxycoformycin (pentostatin). (1983) (3)
- Radiosensitivity of human colon carcinoma cells in vitro and in vivo. Abstr. (1980) (3)
- Clinical and pharmacological studies of methotrexate-minimal leucovorin rescue plus fluorouracil. (1982) (3)
- Characterization of two newly established human pancreatic cancer cell lines grown in monolayer and artificial capillary cultures and in nude mice. Abstr. (1981) (3)
- Phase I study of 5-fluorodeoxyuridine plus cytosine arabinoside infusions in patients with solid tumors. (1979) (3)
- A therapeutic monitoring assay for N-methylformamide in human serum and urine. (1983) (3)
- Effect of 6-azauridine on plasma cell tumors of mice: correlation of antitumor effect with inhibition of orotic acid metabolism. (1967) (3)
- Heterogeneity of mmtv antigen expression and induction in mouse mammary tumor cells. Abstr. (1979) (2)
- Modulation of fudr host toxicity by two benzylacylouridine analogs (1987) (2)
- Tissue analysis of N-methylformamide: organ distribution. (1984) (2)
- Studies on the Role of the Lymphocyte in the Immune Response † (1964) (2)
- Geriatric clinical pharmacologist and medical oncologist: A new partnership? (1997) (2)
- 39th Annual European Brain and Behaviour Society Abstracts (2007) (2)
- Phase I trial of the combination of 6-methylmercaptopurine riboside and 5-fluorouracil (1988) (2)
- Selective immunosuppression with methotrexate and 5-fluorouracil. Abstr. (1973) (2)
- Stimulatory effects of 5-lodo-2'-deoxyuridine on number and function of splenic B- and T-cells and of macrophages in C3HeB/FeJ mice. (1976) (2)
- Different effect of benzylacyclouridine on the toxic and therapeutic effects of azidothymidine in mice. (1990) (2)
- Use of allopurinol for control of hyperuricemia in leukemia and lymphoma. (1967) (2)
- Selective manipulation of immunological responses with with cytosine arabinoside. Abstr. (1970) (2)
- Induction of doxorubicin resistance in heterogeneous human colon tumor cells by N-methylformamide. (1986) (2)
- Studies on the kinetics of marrow regeneration after local irradiation of the femur in rabbits. (1968) (1)
- Book ReviewMedical Care, Medical Costs: The search for a health insurance policy (1987) (1)
- 2'-Deoxycoformycin-induced hemolysis in the mouse. (1982) (1)
- Growth inhibition by polar solvents of human colon cancer xenografts in nude mice. Abstr. (1982) (1)
- Effect of leucovorin on selective immunosuppression with methotrexate (mtx) and 5-fluorouracil (5-fu) in c3heb/fej mice. Abstr. (1975) (1)
- Artificial capillary culture studies of human tumor cell growth, differentiation, and marker production. (1987) (1)
- Mono clonal antibody production in artificial capillary cultures (1981) (1)
- Establishment and Characterization of Two Human Pancreatic Cancer Cell Lines Tumorigenic in Athymic Mice 1 (2006) (1)
- 5’-methylthioadenosine phosphorylase as a chemotherapeutic target enzyme (1982) (1)
- Combination Drug Therapy (2005) (1)
- Human leukocyte reactivity to penicilloylated erythrocytes. (1974) (1)
- Legislative support for access to state-of-the-art cancer treatment in Rhode Island. (1998) (1)
- The value of the fluorescent antiglobin technic in the differential diagnosis of aleukemic leukemia. (1962) (0)
- SYNTHESIS AND BIOLOGICAL EVALUATION OF CERTAIN 4‐ALKYLAMINO AND 4‐ARYLALKYLAMINO DERIVATIVES OF THE IMIDAZO(4,5‐D)PYRIDAZINE AND V‐TRIAZOLO(4,5‐D)PYRIDAZINE RING SYSTEMS (1982) (0)
- Effects of la,25-Dihydroxyvitamin D3 on the Human Chronic Myelogenous Leukemia Cell Line RWLeu-41 (2006) (0)
- Establishment and Characterization of Two Human Pancreatic Cancer Cell Lines Tumorigenic in Athymic Mice1 (2006) (0)
- Results of the National Cancer Advisory Board Evaluation of the National Cancer Program (1996) (0)
- 391 – IDIFFERENCES IN SUSCEPTIBILITY TO ANTI-NEOPLASTIC DRUGS AMONG SUBPOPULATIONS OF TUMOR CELLS OBTAINED FROM A SINGLE TUMOR (1978) (0)
- Selective alteration of immunological competence by mammary tumor virus. Abstr. (1971) (0)
- Quantitative studies of cellular and humoral immune responses to tumor cells after treatment with antineoplastic agents. Abstr. (1969) (0)
- Multiple effects of 5-flourouracil (5-fu) on immunocompetence. Abstr. (1972) (0)
- N,n-dimethylformanide (dmf) induces premature senescence of murine bone marrow cell cultures. Abstr. (1983) (0)
- Medicinske alternative alternativni medicini (2000) (0)
- Report on the Discussion of the Fourth Session (1973) (0)
- Growth of heterologous marrow in difh@@@fusion chambers implan in athymic, "nude" mice. Abstr. (1977) (0)
- CEREBROSPINAL FLUID VASCULAR ENDOTHELIAL GROWTH FACTOR IN PATIENTS WITH BRAIN TUMORS (1997) (0)
- The Rhode Island Cancer Council. (2002) (0)
- Taurolidine or taurultamo for use in treating prostate, colon, lung and for the treatment of recurrent glioblastoma multiforme (2000) (0)
- Synergism of immunosuppressive agents. Abstr. (1973) (0)
- Clinical and Pharmacological Studies of Methotrexate-Minimal Leucovorin Rescue plus Fluorouracil 1 (2006) (0)
- Book ReviewPulmonary Metastasis (1979) (0)
- Changes in the in vivo patterns and subsequent metastasis development of indium-111 radiolabeled b16 melanoma cells after growth in dimethylformamide (dmf). Abstr. (1982) (0)
- Discussion (1972) (0)
- Community cancer control task forces in Rhode Island. (2004) (0)
- Triacetyl 6-Azauridine in Mycosis Fungoides (1968) (0)
- Gastric pepsin secretion and ABO blood groups in polycythemia vera (1959) (0)
- Book ReviewIn Search of Equity: Health needs and the health care system (1983) (0)
- A human pancreatic adenocarcinoma (rwp 1) which metastasizes in athymic mice. Abstr. (1982) (0)
- Myelogenous Leukemia Cell Line RWLeu-4 on the Human Chronic 3 , 25-Dihydroxyvitamin D α Effects of 1 Updated (2006) (0)
- Activation of the fibroblast growth factor receptor associated tyrosine kinase in normal human fibroblasts (1989) (0)
- In vitro hyperthermic sensitivities of a heterogeneous human colon adenocar cinoma (1980) (0)
- Inhibition by puromycin in vitro of cell-bound immunity induced by tumor homografts. Abstr. (1967) (0)
- Use of taurolidine or taurultamo for the manufacture of a medicament for the treatment of tumors (2000) (0)
- Incorporation of iododeoxyuridine into neoplastic DNA: A fraudulent magic bullet? (1990) (0)
- Medicine in the year 2000: a symposium. (1978) (0)
- Medical oncology manpower training: a position statement of the American Society of Clinical Oncology. (1985) (0)
- / V , / V-Dimethylformamide and Sodium Butyrate Modulation of the Activities of Purine-metabolizing Enzymes in Cultured Human Colon Carcinoma Cells 1 (2006) (0)
- 458 – ANALYSIS OF ADVERSE DRUG REACTIONS IN HOSPITALIZED PATIENTS (1977) (0)
- Book ReviewRural Health Care (1983) (0)
- A Clinical and PharmacologicalStudy of High-Dose Methotrexate with Minimal Leucovorin Rescue1 (2006) (0)
- Potentially curable neoplasms. (1986) (0)
- The effect of thymidine (tdr) upon combination chemotherapy with 5-fluoro-2'-deoxyuridine (f) and 5-iodo-2'-deoxyuridine (i). Abstr. (1978) (0)
- Sensitivity of l5178y cells in culture to antileukemic agents after treatment with l-asparaginase and l-asparagine rescue. Abstr. (1970) (0)
- Cancer in the new millennium. (2002) (0)
- DETERMINANTS OF MATERNAL AND INFANTICIDAL BEHAVIOR IN FEMALE MOUSE F1 HYBRIDS (2007) (0)
- Subject Index, Vol. 55, 1997 (1997) (0)
- Melanosis in nude mice bearing a human melanoma xenograft. Abstr. (1981) (0)
- Book ReviewBoston at Risk: A report from The Boston Foundation Primary Health Care Seminar (1986) (0)
- Synergism of Methotrexate with 1 muran and with 5-Fluorouracil and Their Effects on Hemolysin Plaque-forming Cell Production in the Mouse 1 (2006) (0)
- Synergism of Methotrexate with 1muran and with 5-Fluorouracil and Their Effects on Hemolysin Plaque-forming Cell Production in the Mouse1 (2006) (0)
- Contents, Vol. 55, 1997 (1997) (0)
- From the chairman (0)
- Future horizons in clinical pharmacology. (1968) (0)
- ABLE 2 EXCRETION PRODUCTS IN URINE AFTER AZUR THERAPY Diagnosis Acute monocytie leukemia Chronic granulocytic leukemia Acute granuloeytic leukemia Acute granuloeytie leukemia Hodgkin ' s disease Patient (2007) (0)
- Advances in Brief Antitumor Activity of Basic Fibroblast Growth Factor-Saporin Mitotoxin in Vitro and in Vivo ' (2006) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Paul Calabresi?
Paul Calabresi is affiliated with the following schools: